Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.061 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |